AUTOLOGOUS TRANSPLANTATION: Purging and the Impact of Minimal Residual Disease
- 1 October 1999
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 13 (5) , 969-986
- https://doi.org/10.1016/s0889-8588(05)70105-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- CD34+‐selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcomeBritish Journal of Haematology, 1999
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998
- Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- Negative selection and protection of normal progenitor cells for autograftingBone Marrow Transplantation, 1998
- Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantationBone Marrow Transplantation, 1997
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myelomaBritish Journal of Haematology, 1995
- Gene-marking to trace origin of relapse after autologous bone-marrow transplantationThe Lancet, 1993
- Clinical Models of Autotransplants in Chronic Myelogenous LeukemiaLeukemia & Lymphoma, 1993
- Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell LymphomaNew England Journal of Medicine, 1991